| Literature DB >> 2206792 |
J Geneve1, T Le Dinh, A Brouard, M Bails, J M Segrestaa, C Caulin.
Abstract
Enalapril maleate, an angiotensin converting enzyme inhibitor, is a vasodilator liable to modify regional blood flow. The effects of an oral dose of 40 mg enalapril maleate on indocyanine green (ICG) kinetics were assessed in nine healthy subjects. At 4 h after the administration of the drug, a 35% decrease in ICG clearance was observed (P less than 0.01) associated with a 23% decrease in its volume of distribution (P less than 0.02). The half-life of ICG was not altered significantly by enalapril. These results suggest that the administration of enalapril maleate to healthy subjects may reduce apparent liver plasma flow and plasma volume, as a consequence of the pooling of blood in the hepatosplanchnic area.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2206792 PMCID: PMC1368232 DOI: 10.1111/j.1365-2125.1990.tb03779.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335